GREM1 acts in leptin receptor-expressing skeletal cells to mediate peri-implant fibrosis

Read full text Summarise with VIRAT
Authors: Vincentius Jeremy Suhardi, Anastasia Oktarina, Yingzhen Niu, Andrew L. Thomson, Jϋrgen Alphonsus, Nicolas Matthew Suhardi, Jason McCormick, Ugur M. Ayturk, Matthew Blake Greenblatt, Lionel B. Ivashkiv, Mathias P. G. Bostrom, Xu Yang
Cited by: 0
References: 112

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Globally, approximately 1.3 million total joint implants are placed annually, and around 80,000 patients develop aseptic loosening, a leading cause of implant failure driven by peri-implant fibrosis. Here, we show that the BMP-antagonist Gremlin-1 (GREM1), expressed by leptin receptor–expressing skeletal (LEPR⁺) cells, is a key regulator of this process. GREM1 is highly expressed by LEPR⁺ cells in peri-implant fibrotic tissue in mice and humans. Conditional deletion of Grem1 in LEPR⁺ cells attenuate peri-implant fibrosis and enhances peri-implant osteogenesis. Transcriptomic and functional analyses show that loss of Grem1 in LEPR⁺ cells upregulate the bone morphogenetic protein (BMP) and WNT pathways, increasing in vivo osteogenesis and reducing fibrous tissue formation. As proof-of-concept, intra-articular administration of a neutralizing antibody against GREM1 (anti-GREM1) in mice prevents and reverses peri-implant fibrous tissue while promoting peri-implant bone formation. Inhibition of GREM1 in LEPR⁺ cells therefore represent a promising strategy to prevent and treat aseptic loosening. About 1.3 million total joint implants are placed annually, and around 80,000 patients develop implant failure due to periimplant fibrosis. Here, the authors show that inhibition of GREM1 in LEPR⁺ cells reduces peri-implant fibrosis and enhances per-implant osteogenesis, therefore represent a promising strategy to prevent and treat aseptic loosening.

Fields of Study & Subjects

Orthopaedic implants and arthroplasty Osteoarthritis Treatment and Mechanisms Orthopedic Infections and Treatments

Publication details

Journal / source
Nature Communications
Volume
17
Issue
1
Publication date
23 March 2026
Language
EN